A new study from researchers at Intermountain Health in Salt Lake City found that starting an advanced medication earlier for critically ill patients with life-threatening septic shock does not ...

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) ("Estrella" or the "Company"), a clinical-stage biopharmaceutical company developing CD19- and CD22-targeted ARTEMIS® T-cell therapies to treat ...

Brigham Young University’s much-anticipated medical school now has an opening date — and students hoping to be part of its ...

For the third consecutive year, the three Intermountain Health Primary Children’s Hospital campuses in Utah have been ranked ...

The Murray Planning Commission approved a conditional use permit so Intermountain Health can build a cancer center at its ...

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) has activated Intermountain Health LDS Hospital in Salt Lake City, Utah, as the fifth clinical site for its ongoing STARLIGHT-1 Phase I/II trial ...

The BYU School of Medicine has received preliminary accreditation from the Liaison Committee on Medical Education (LCME), the ...

Intermountain Health is expanding access to specialized care close to home with the opening of the new Saratoga Springs ...

A new study from researchers at Intermountain Health in Salt Lake City found that starting an advanced medication earlier for ...

BREAKING: The BYU School of Medicine has received preliminary accreditation from the Liaison Committee on Medical Education ...

For the third consecutive year, the three Intermountain Health Primary Children's Hospital campuses in Utah have been ranked among the nation's best children’s hospitals in all 11 pediatric ...

Pamela Atkinson, a tireless advocate and organizer for Utahns who needed help — children, the elderly and people dealing with ...